ReNeuron Group plc (LON:RENE – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 3.38 ($0.04) and traded as high as GBX 3.50 ($0.04). ReNeuron Group shares last traded at GBX 3.38 ($0.04), with a volume of 177,373 shares trading hands.
ReNeuron Group Price Performance
The company has a fifty day simple moving average of GBX 3.38 and a two-hundred day simple moving average of GBX 3.61. The company has a debt-to-equity ratio of 14.25, a quick ratio of 2.02 and a current ratio of 1.51. The company has a market capitalization of £1.93 million, a price-to-earnings ratio of -37.50 and a beta of 0.67.
About ReNeuron Group
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.
Featured Articles
- Five stocks we like better than ReNeuron Group
- Bank Stocks – Best Bank Stocks to Invest In
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- When to Sell a Stock for Profit or Loss
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.
